213 related articles for article (PubMed ID: 2480016)
1. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation.
Keating MT; Escobedo JA; Fantl WJ; Williams LT
Trans Assoc Am Physicians; 1988; 101():24-32. PubMed ID: 2480016
[TBL] [Abstract][Full Text] [Related]
2. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation.
Keating MT; Escobedo JA; Williams LT
J Biol Chem; 1988 Sep; 263(26):12805-8. PubMed ID: 2843499
[TBL] [Abstract][Full Text] [Related]
3. A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF.
Escobedo JA; Williams LT
Nature; 1988 Sep; 335(6185):85-7. PubMed ID: 2842689
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation.
Taverna D; Groner B; Hynes NE
Cell Growth Differ; 1991 Mar; 2(3):145-54. PubMed ID: 1676295
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta 1 inhibitory effect of platelet-derived growth factor-induced signal transduction on human bone marrow fibroblasts: possible involvement of protein phosphatases.
Fontenay M; Bryckaert M; Tobelem G
J Cell Physiol; 1992 Sep; 152(3):507-19. PubMed ID: 1324246
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the platelet-derived growth factor-dependent tyrosine kinase activity in sparse and confluent fibroblasts.
Kazlauskas A; DiCorleto PE
J Cell Physiol; 1986 Feb; 126(2):225-36. PubMed ID: 3003124
[TBL] [Abstract][Full Text] [Related]
9. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J
Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109
[TBL] [Abstract][Full Text] [Related]
10. Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization.
Sorkin A; Eriksson A; Heldin CH; Westermark B; Claesson-Welsh L
J Cell Physiol; 1993 Aug; 156(2):373-82. PubMed ID: 7688373
[TBL] [Abstract][Full Text] [Related]
11. Differential binding, biological and biochemical actions of recombinant PDGF AA, AB, and BB molecules on connective tissue cells.
Grotendorst GR; Igarashi A; Larson R; Soma Y; Charette M
J Cell Physiol; 1991 Nov; 149(2):235-43. PubMed ID: 1660900
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a high-molecular-weight protein immunoprecipitated by platelet-derived growth factor antisera.
Graves DT; Antoniades HN
J Cell Physiol; 1988 Nov; 137(2):263-71. PubMed ID: 2461374
[TBL] [Abstract][Full Text] [Related]
13. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
16. Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity.
Wang YZ; Wharton W; Garcia R; Kraker A; Jove R; Pledger WJ
Oncogene; 2000 Apr; 19(17):2075-85. PubMed ID: 10815799
[TBL] [Abstract][Full Text] [Related]
17. PDGF induces c-myc mRNA expression in MG-63 human osteosarcoma cells but does not stimulate cell replication.
Womer RB; Frick K; Mitchell CD; Ross AH; Bishayee S; Scher CD
J Cell Physiol; 1987 Jul; 132(1):65-72. PubMed ID: 2439522
[TBL] [Abstract][Full Text] [Related]
18. [The characteristics of the internalization of normal and mutant receptors for the growth factor released by thrombocytes].
D'iakonova MIu; Sorkin AD; Nikol'skiĭ NN
Tsitologiia; 1992; 34(8):74-81. PubMed ID: 1293877
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumor cell proliferation in vitro.
Fleming TP; Matsui T; Heidaran MA; Molloy CJ; Artrip J; Aaronson SA
Oncogene; 1992 Jul; 7(7):1355-9. PubMed ID: 1320245
[TBL] [Abstract][Full Text] [Related]
20. A common PDGF receptor is activated by homodimeric A and B forms of PDGF.
Escobedo JA; Navankasatussas S; Cousens LS; Coughlin SR; Bell GI; Williams LT
Science; 1988 Jun; 240(4858):1532-4. PubMed ID: 2836953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
